Islet Interleukin-1β Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to β-Cell Failure.
Saved in:
| Title: | Islet Interleukin-1β Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to β-Cell Failure. |
|---|---|
| Authors: | Hull RL; Department of Medicine, University of Washington, Seattle, WA rhull@uw.edu srinath.sanda@ucsf.edu., Gibson RL; Department of Pediatrics, University of Washington, Seattle, WA., McNamara S; Department of Pediatrics, University of Washington, Seattle, WA., Deutsch GH; Department of Pathology, University of Washington, Seattle, WA., Fligner CL; Department of Pathology, University of Washington, Seattle, WA., Frevert CW; Department of Medicine, University of Washington, Seattle, WA.; Department of Comparative Medicine, University of Washington, Seattle, WA., Ramsey BW; Department of Pediatrics, University of Washington, Seattle, WA., Sanda S; Department of Pediatrics, University of California, San Francisco, San Francisco, CA rhull@uw.edu srinath.sanda@ucsf.edu.; Diabetes Center, University of California, San Francisco, San Francisco, CA. |
| Source: | Diabetes care [Diabetes Care] 2018 Apr; Vol. 41 (4), pp. 823-830. Date of Electronic Publication: 2018 Feb 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
